MobCraft Walker's Point taproom to reopen under new owners with some of its flagship beers
The new owners are Sarah Halstead, who worked at MobCraft for four years, and her husband, Michael.
They purchased the brewery for $160,000.
"We thought it would be a neat opportunity," Halstead said.
They plan to bring back flagship beers like BatSh!t Crazy and Out Of Office. The also plan to serve appetizers, sandwiches and pizzas, including MobCraft's Whitewater mac and cheese pizza.
What else might change or stay the same at the taproom at 505 S. Fifth St. is still being decided, Halstead said.
They do plan to bring back some festivals, but Halstead wasn't sure which ones. MobCraft was popular for its Stout Fest, Sour Fest and Weird Fest.
The Halsteads are only reopening the Milwaukee taproom. When MobCraft closed, it also had a location in Woodstock, Illinois.
The couple is waiting for license and health department approvals and is hoping to reopen the brewery in May.
MobCraft Beer announced in October that it would be closing after eight years.
MobCraft CEO Henry Schwartz said in a news release that the brewery "reached a point where we could no longer operate as a stand-alone operation."
MobCraft Beer was founded in Madison in 2013 by Henry Schwartz, Andrew Gierczak and Giotto Troia, who met at the University of Wisconsin-Whitewater and launched their business in Madison.
In 2016 MobCraft moved its business from Madison to Milwaukee when it opened the Walker's Point taproom.
In 2021, MobCraft announced it would open three additional taprooms: in Waterford; Woodstock, Illinois; and Denver. MobCraft was looking to raise up to $2.25 million in an equity crowdfunding campaign to fund the ventures. Its investment platform, wefunder, shows it closed fundraising in April 2022 after it raised $845,000 from 488 investors.
MobCraft Denver was open from September 2022 until it closed in April 2023.
The Waterford location never opened, which the village sued MobCraft for.
MobCraft opened the Woodstock location in November 2023 and closed it along with the Milwaukee taproom this past November.
This article originally appeared on Milwaukee Journal Sentinel: Milwaukee brewery MobCraft Beer to reopen under new owners
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
FIC Closes on Continuation Vehicle, Advancing its Existing Collaboration with Matterhorn Express Pipeline
HOUSTON & CHARLOTTE, N.C., July 28, 2025--(BUSINESS WIRE)--FIC, an investment firm with a focus on critical infrastructure assets across the energy and power use value chains, has closed on a GP-led secondary transaction for a portion of its existing equity interest in the Matterhorn Express Pipeline (Matterhorn). Matterhorn is a strategically positioned natural gas pipeline with a capacity of 2.5 billion cubic feet per day (Bcf/d), linking the Permian Basin to essential demand centers across Texas and the Gulf Coast—from power generation and industrial markets to LNG export terminals. Matterhorn was placed into service in November 2024 and is fully contracted. "FIC is excited about continuing its successful partnership with the WhiteWater team through the next phase of growth for Matterhorn," said Cay Freihofer, Co-Managing Partner of FIC. "Matterhorn is a world-class infrastructure platform, well positioned to serve essential and growing demand centers that we believe position the investment for continued success," added Co-Managing Partner Cyrus Aghili. A diverse syndicate of high-quality institutional investors provided new capital for the continuation vehicle. The transaction allows FIC to support the platform's future growth while providing FIC's pre-existing limited partners the opportunity to monetize performance on a successful investment in Matterhorn. Following the transaction, funds managed by FIC own WhiteWater Matterhorn InvestCo, LLC ("MXP HoldCo") alongside I Squared and WhiteWater Midstream. WhiteWater Midstream, through MXP HoldCo, operates Matterhorn. Evercore acted as financial advisor and exclusive placement agent to FIC on the transaction, while Latham & Watkins and Milbank provided legal counsel. About FIC FIC Partners Management, LP ("FIC") is an investment firm with a focus on critical infrastructure assets across the energy and power use value chains. FIC focuses on investment opportunities that seek to generate long-term capital appreciation in the gas transmission, downstream, power and utilities, renewables, and data/telecommunications industries. We partner with management teams and businesses to help accelerate the development of strategic assets that serve society's growing energy needs and the associated decarbonization of industrial infrastructure. FIC is the renamed firm following the merger of Emerald Bridge Capital, LP and First Infrastructure Capital Advisors, LLC. For more information about FIC, please visit View source version on Contacts Media Contact :FIC Partners Management, LPEmail: info@
Yahoo
21-07-2025
- Yahoo
Organ Preservation Market worth $0.3 billion by 2030 with 6.8% CAGR
DELRAY BEACH, Fla., July 21, 2025 /PRNewswire/ --The global Organ Preservation Market, valued at US$0.1 billion in 2024 stood at US$0.2 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$0.3 billion by the end of the period. The organ preservation market is experiencing robust growth fueled by rising incidence of chronic diseases, organ failure, and advancements in transplantation procedures. Increasing rates of end-stage organ conditions—such as kidney, liver, and heart failure—combined with a growing global demand for transplant procedures are key factors accelerating market expansion. The aging population, more susceptible to organ dysfunction, further highlights the increasing need for effective preservation methods to maintain organ viability pre-transplantation. Technological progress in preservation techniques, including hypothermic and normothermic perfusion, is transforming the standard of care by enhancing organ function and extending preservation times. In parallel, developing innovative preservation solutions such as the University of Wisconsin (UW) solution and Custodiol HTK significantly improves transplantation outcomes. Rising awareness among healthcare providers and the public about timely organ donation and preservation is increasing product adoption. Expanding hospital transplant programs, supportive government initiatives, and improved healthcare infrastructure in emerging markets also drive market momentum. Download PDF Brochure: Browse in-depth TOC on "Organ Preservation Market" 300 - Tables 100 - Figures 400 - Pages By solution, the organ preservation market, by solution, is categorized into UW Solution, Custodial HTK, Perfadex, and other solutions (including EuroCollins and Celsior). The UW (University of Wisconsin) solution accounted for the largest market share in 2024. This solution is widely used for preserving and flushing organs such as the liver, kidneys, and pancreas. As the first intracellular solution introduced for this purpose, it has become the benchmark in organ preservation. The dominance of the UW solution can be credited to its high efficacy in improving transplant outcomes. This is primarily due to the inclusion of metabolically inactive compounds like lactobionate and raffinose, which help reduce tissue damage, maintain cellular integrity, and enhance the physiological viability of organs during storage. These advantages have made the UW solution preferred over alternative preservation media. By technique, the static cold storage segment is expected to dominate the market due to its simplicity, cost-effectiveness, and widespread use in preserving kidneys, liver, and pancreas. While newer technologies such as hypothermic machines and normothermic perfusion are gaining traction, especially for heart and lung preservation, static cold storage remains the gold standard in many transplant centers worldwide. In addition, ongoing advancements in perfusion technologies and a growing focus on organ quality optimization before transplantation are expanding the market. The increasing initiatives by governments and non-profits to promote organ donation, along with improvements in preservation solutions and transportation logistics, are further contributing to market growth. As the demand for transplantable organs continues to outpace supply, efficient and advanced preservation methods become more crucial in ensuring transplant success. By organ type, Organ preservation, categorized by organ type, includes kidneys, liver, lungs, heart, and pancreas. In 2024, the kidney segment emerged as the leading contributor to the market. This prominence is primarily due to the rising prevalence of end-stage renal disease (ESRD), for which kidney transplantation remains the most effective treatment option. As kidney failure cases continue to grow, so does the number of transplant procedures, necessitating efficient preservation of donor kidneys before implantation in recipients. By end user, the organ preservation market is divided into transplant centers, hospitals, and specialty clinics. In 2024, the organ transplant centers segment accounted for the largest share of the market. The large share of this segment can be attributed to the extensive establishment of healthcare facilities that operate dedicated transplant programs. These centers are central to organ retrieval, preservation, and transplantation, making them critical consumers of preservation products and technologies. By geography, The Asia Pacific region is projected to grow at the highest CAGR during the forecast period. The high growth rate of the Asia Pacific region is attributed to supportive government policies, rising public awareness regarding organ donation, and a surge in organ donation activities. Countries like China and Japan have implemented standardized national guidelines for organ donation and transplantation, which are playing a key role in advancing the market. Additionally, improvements in healthcare infrastructure, the increasing burden of chronic illnesses, and the rise of medical tourism across several countries in the region are expected to fuel the market growth during the forecast period. Request Sample Pages : The prominent players in the global organ preservation market are Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions, Inc. (US), and TX Innovations (Netherlands). Paragonix (US): Paragonix is the leading market player in organ preservation. It operates mainly in the US and Europe. The company has been focused on developments such as new product launches, partnerships, agreements, and approvals since 2016. The company has developed devices for all thoracic & abdominal organ preservation. Paragonix also focuses on software services and tools for real-time organ tracking. Paragonix partnered with the Lung Transplant Foundation (US) to develop various technologies to improve donor lung preservation. In January 2021, the company partnered with Southwest Transplant Alliance (STA) to provide advanced organ preservation technologies. Such a development proves the company's strong market prevalence. XVIVO Perfusion AB (Sweden) XVIVO Perfusion AB is a prominent market and public domain company. It is headquartered in Sweden and operates in Europe, Asia, the Middle East, and North & South America. It spends nearly 31% of its revenue on R&D, which is why the company is involved in developing improved products for organ perfusion. XVIVO's lung perfusion solution is used mainly in Lung Preservation, making the solution a gold standard. In September 2020, XVIVO Perfusion entered an acquisition agreement with Organ Assist. This agreement further strengthened the company's product range and expanded its addressable market. Dr. Franz Kohler Chemie GmbH (Germany) Dr. Franz Kohler Chemie GmbH is a leading market player in organ preservation solutions since 1959. It involves developing electrolyte solutions, organ-protective solutions, therapeutics, antidotes, X-ray contrast agents, and medical devices. It has captured the market for Custodial, an organ preservation solution. Custodial holds advantages over other solutions, like reduced viscosity and an improved graft survival rate, and is widely used to preserve all organs, unlike other solutions. These advantages of a Custodial solution for organ preservation prove that Dr. Franz Kohler Chemie GMBH holds a substantial market prevalence. For more information, Inquire Now! Related Reports: Biopreservation Market Cardiac Monitoring & Cardiac Rhythm Management Devices Market Electrophysiology Market Human Organoids Market Transplant Diagnostics Market Get access to the latest updates on Organ Preservation Companies and Organ Preservation Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Sign in to access your portfolio
Yahoo
18-07-2025
- Yahoo
I'm a 28-year-old AI engineer in Big Tech. Here's my advice for others who want to break into this growing field.
Kriti Goyal leveraged her master's degree to advance her AI career in the US. She pitched projects internally during her internship that were adopted to help secure a full-time offer. Higher education aids in tech careers, but networking and skills can also open doors. This as-told-to essay is based on a conversation with Kriti Goyal, a 28-year-old AI machine learning engineer based in Seattle, about her journey into her current role and her daily schedule. It's been edited for length and clarity. I was mostly raised in the small town of Bikaner, Rajasthan, in India, and I always thought I would study medicine until my cousin showed me a video that changed my life. It was a video with Mark Zuckerberg, Bill Gates, and other tech rockstars, about how coding is the quickest way to convert an idea into a product. That video was a very big turning point in my life and career. I'm now part of the Foundation Model main framework team for a major Big Tech company in the US. I recently completed five years with them, during which time I've held four different roles. I used my master's to move to the US and further my career. But whether or not a higher degree is necessary today is complicated. There are many roles on machine learning teams There are multiple rungs on the ladder of Machine Learning teams. The different roles include researchers, engineers calling on the machine learning models and building applications on top, and the core machine learning people who are developing the actual model itself. Finally, you have the infrastructure stack barrier, doing the product center toolkits to help machine learning teams. I work on building the foundation of machine learning models, which means I build code that trains software to recognize unseen data and create patterns. I started my tech career as an intern in India, but knew I had to come to the US to advance I originally interned at my current company in India. I enjoyed working in India; the work was great, but the core business decisions and figuring out the strategy of the next project were happening at the company headquarters here in the US. I had no intention of moving to the US earlier. I was quite happy in my country. But overall, I kept feeling like I wasn't doing the best I could in my career because of living so far from the core business decisions, and I decided I wanted to make the move. I used my internship and master's to get further in AI engineering I had two ways to go about moving to the US: one was to try to move from within my company, or get a master's. There were two reasons I chose the master's path: the knowledge and extra specialty you can develop through projects and the connections you make. The biggest thing I took away from my master's program at the University of Wisconsin-Madison was definitely the people. When I got to the US, I knew a few people at my former company already from my time in India, so I reached out to a bunch of managers directly instead of applying on the job board. I got the interview for the Machine Learning engineering internship quite easily because they were aware of me and my work from before. Pitching my products internally helped me land a full-time AI engineering role When I started as an intern again, this time in the US, I did a few things that helped me land this job. I pitched my product to other teams internally to get it adopted. My manager kept telling me that, when they were fighting to get me into the company full time, that was a major thing they used. Now, as an engineer on the machine learning team, I like to segment my day into three parts. It sort of depends on the project life cycle, but usually, I start by researching. The second part is upstream and downstream check-ins with other team members and clients. I speak with people on other teams, saying, "Hey, this is what we can do, and does this work for you?" Everyone's favorite part is the third, which is basically hands-on building and coding. I'm lucky enough to spend most of my time being an individual contributor and focusing on coding. Higher education in tech still matters, but there are other ways I think it's possible now to skip that education stage. But I have seen a bias in hiring for specific teams, and it's not unbreakable yet. I was changing countries and cultures, and university was a great way to get through the immigration system and understand the culture. I needed it. If you want to be in academia and teaching, the higher education path makes sense. But if you want to build something fast, learning and networking can be done in many places. In a city like San Francisco or New York, you could hustle and get the networking benefits of a university and a structured system. You essentially just need the ability to prove that you can be good at the job. That doesn't really come from a degree. But I find there is usually some bias against applicants without a degree higher than a bachelor's. Do you have a story to share about AI or higher education bias in tech? Contact this reporter, Agnes Applegate, at aapplegate@ Read the original article on Business Insider Solve the daily Crossword
